These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4604487)

  • 41. [Active transport of fosfomycin into cells of Escherichia coli, multidrug-resistant Pseudomonas aeruginosa and Staphylococcus aureus].
    Tsuruoka T; Miyata A; Inouye S
    Jpn J Antibiot; 1995 Dec; 48(12):1935-8. PubMed ID: 8587167
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Growth curves of Escherichia coli submitted to fosfomycin].
    Yourassowsky E; Van der Linden MP; Lismont MJ; Crokaert F
    Pathol Biol (Paris); 1983 Jun; 31(6):512-4. PubMed ID: 6348659
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biosynthesis of the peptidoglycan of Escherichia coli K-12: properties of the in vitro polymerization by transglycosylation.
    van Heijenoort Y; van Heijenoort J
    FEBS Lett; 1980 Feb; 110(2):241-4. PubMed ID: 6989635
    [No Abstract]   [Full Text] [Related]  

  • 44. Prediction of antibiotic resistance by gene expression profiles.
    Suzuki S; Horinouchi T; Furusawa C
    Nat Commun; 2014 Dec; 5():5792. PubMed ID: 25517437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elevated Expression of GlpT and UhpT via FNR Activation Contributes to Increased Fosfomycin Susceptibility in Escherichia coli under Anaerobic Conditions.
    Kurabayashi K; Tanimoto K; Fueki S; Tomita H; Hirakawa H
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6352-60. PubMed ID: 26248376
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of moenomycin on Escherichia coli.
    van Heijenoort Y; Leduc M; Singer H; van Heijenoort J
    J Gen Microbiol; 1987 Mar; 133(3):667-74. PubMed ID: 3309167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The problems of drug-resistant pathogenic bacteria. Studies on R factors segregated into E. coli minicells.
    Levy SB
    Ann N Y Acad Sci; 1971 Jun; 182():217-25. PubMed ID: 4936663
    [No Abstract]   [Full Text] [Related]  

  • 48. Biological cost of fosfomycin resistance in Escherichia coli in a murine model of urinary tract infection.
    Pourbaix A; Guérin F; Lastours V; Chau F; Auzou M; Boulley E; Cattoir V; Fantin B
    Int J Med Microbiol; 2017 Dec; 307(8):452-459. PubMed ID: 28986014
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Infectious drug resistance in Thailand. II. Infectious drug resistance in Escherichia coli isolated from healthy adults and hospitalized patients in Bangkok.
    Koonkhamlert C; Sawyer WD
    J Med Assoc Thai; 1971 Nov; 54(11):794-803. PubMed ID: 4942858
    [No Abstract]   [Full Text] [Related]  

  • 50. Host cell changes induced by R factors and other sex factors.
    Watanabe T; Ogata Y; Sugawara K; Oda K; Saito T
    Johns Hopkins Med J Suppl; 1973; 2():98-114. PubMed ID: 4606621
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effect of chloramphenicol and its acetylated derivatives on the synthesis of proteins].
    Piffaretti JC; Allet B
    Pathol Microbiol (Basel); 1970; 36(5):303-4. PubMed ID: 4935371
    [No Abstract]   [Full Text] [Related]  

  • 52. Cross resistance of Escherichia coli B ribosomes to inhibition of the puromycin reaction by erythromycin, spiramycin and chloramphenicol.
    Cerná J; Rychlík I
    Biochim Biophys Acta; 1968 Apr; 157(2):436-8. PubMed ID: 4870247
    [No Abstract]   [Full Text] [Related]  

  • 53. Outer membrane of Escherichia coli K-12: TSX mutants (resistant to bacteriophage T6 and colicin K) lack an outer membrane protein.
    Manning PA; Reeves P
    Biochem Biophys Res Commun; 1976 Jul; 71(2):466-71. PubMed ID: 786287
    [No Abstract]   [Full Text] [Related]  

  • 54. Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli.
    Takahata S; Ida T; Hiraishi T; Sakakibara S; Maebashi K; Terada S; Muratani T; Matsumoto T; Nakahama C; Tomono K
    Int J Antimicrob Agents; 2010 Apr; 35(4):333-7. PubMed ID: 20071153
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autoradiographic analysis of diaminopimelic acid incorporation in filamentous cells of Escherichia coli: repression of peptidoglycan synthesis around the nucleoid.
    Mulder E; Woldringh CL
    J Bacteriol; 1991 Aug; 173(15):4751-6. PubMed ID: 1856170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
    Oteo J; Orden B; Bautista V; Cuevas O; Arroyo M; Martínez-Ruiz R; Pérez-Vázquez M; Alcaraz M; García-Cobos S; Campos J
    J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emergence of Plasmid-Mediated Fosfomycin-Resistance Genes among Escherichia coli Isolates, France.
    Benzerara Y; Gallah S; Hommeril B; Genel N; Decré D; Rottman M; Arlet G
    Emerg Infect Dis; 2017 Sep; 23(9):1564-1567. PubMed ID: 28820368
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Transforming RNA bearers of hereditary characters in showdomycino-resistant Escherichia coli].
    Beljanski M; Bourgarel P
    C R Acad Hebd Seances Acad Sci D; 1971 Apr; 272(16):2107-10. PubMed ID: 4996403
    [No Abstract]   [Full Text] [Related]  

  • 59. Change in the cell envelope of Escherichia coli carrying the thermosensitive drug resistance factor, Rts 1, at the nonpermissive temperature.
    DiJoseph CG; Kaji A
    Antimicrob Agents Chemother; 1975 Oct; 8(4):504-9. PubMed ID: 1103727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship between sex-pili formation and macarbomycin sensitivity in Escherichia coli.
    Iyobe S; Mitsuhashi S; Umezawa H
    J Bacteriol; 1971 Nov; 108(2):946-7. PubMed ID: 4942772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.